On February 26th, the New York State Drug Utilization Review Board will meet to review and recommend NYS Medicaid clinical criteria for Viekira Pak - the most recently approved Hepatitis C therapy - marketed by AbbVie.
Tag Archive for: Open for Comment
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Upcoming Events
Notice
There are no upcoming events.
News & Recent Posts
- Hepatitis A, B and C in New York City: 2024 Annual Report March 30, 2026
- Advocacy | NYC Council Educational Briefing on Viral Hepatitis February 2026 March 20, 2026
- Hep Free NYC Meeting Highlights | 03-04-2026 March 18, 2026
- Job | Check Hep C Patient Navigator February 9, 2026
- Application | Harm Reduction Peer Academy @ Housing Works (Due January 30, 2025) January 10, 2026
